Skip to main content

2.

Formation of bone marrow progenitor colonies in from AI-prone MRL-lpr/lpr and control non-autoimmune mice

Group description Visual symptoms Group number Number of mice Number of colonies*
BFU-E CFU-GM CFU-GEMM
CBA (3–7 months) no 1 8 3.0 ± 0.5** 7.3 ± 1.0** 0.25 ± 0.05**
MRL-lpr/lpr males
Healthy (2–3 months)ζ no 3 5 6.5 ± 1.5 7.0 ± 1.0 0.5 ± 0.1
Healthy, pre-diseased (7 months)ζ no 5 5 12.7 ± 1.4 30.0 ± 1.3 9.2 ± 1.9
Diseased (7 months) yes 7 5 25.3 ± 9.8 7.4 ± 0.4 3.9 ± 2.0
Immunized (3 months) yes, weak 9 5 7.0 ± 2.1 6.0 ± 2.6 0.9 ± 0.7
MRL-lpr/lpr females
Healthy (2–3 months)ζ no 4 5 5.5 ± 0.5 11 ± 2.5 0.5 ± 0.2
Healthy, pre-diseased (7 months)ζ no 6 5 11.5 ± 2.0 23.0 ± 3.0 8.2 ± 3.0
Diseased (7 months) yes 8 5 22.1 ± 8.0 9.0 ± 3.9 2.4 ± 1.8
Pregnant (3 months) no 10 5 6.8 ± 2.0 7.8 ± 1.5 0.1 ± 0.08
Lactating (3 months), 4 days after delivery no 11 5 8.8 ± 2.0 19.1 ± 1.8 0.25 ± 0.2
Lactating (3 months), 14 days after delivery no 12 5 21.0 ± 8.0 9.7 ± 0.5 2.1 ± 0.7
*

For each mouse, the mean of four repeats is used. ** Mean ± confidence interval

ζ

MRL-lpr/lpr mice demonstrating no SLE indexes and showing these indexes similar to healthy control non-autoimmune mice were conditionally designated (independently of age) as healthy MRL-lpr/lpr mice; similar animals demonstrating detectable levels of abzymes were conditionally designated as pre-diseased. ΦCohorts with statistically significant (P≤ 0.05) differences in the parameters in comparison with conditionally healthy MRL-lpr/lpr males and females are given in boldface.